Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

Cancer

Volumn 77, Issue 4, 1996, Pages 697-709

  Marcus, Joseph N ^a,e   Watson, Patrice ^a   Page, David L ^b   Narod, Steven A ^c   Lenoir, Gilbert M ^d   Tonin, Patricia ^c   Linder Stephenson, Lisa ^a   Salerno, Giovanni ^a   Conway, Theresa A ^a   Lynch, Henry T ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e ST LUKE S HOSPITAL   (United States)

Author keywords

BRCA1 gene; BRCA2 gene; DNA cytometry; genetic evolution; hereditary breast cancer; pathology; tubular lobular group (TLG)

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER SUSCEPTIBILITY; CHROMOSOME 13Q; CHROMOSOME 17Q; CONTROLLED STUDY; DNA DETERMINATION; FAMILIAL CANCER; FLOW CYTOMETRY; GENETIC LINKAGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; ANEUPLOIDY; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CELL NUCLEUS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 17; DIPLOIDY; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; MITOTIC INDEX; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PLOIDIES; RECURRENCE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSCRIPTION FACTORS;

EID: 13344262707     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W     Document Type: Article

References (67)

1. Lynch HT, Lynch JF. Breast cancer genetics in an oncology clinic: 328 consecutive patients. Cancer Genet Cytogenet 1986;22:369-71.
2. Newman B, Austin MA, Lee M, King M-C. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci USA 1988;85:3044-8.
3. Lynch HT, Marcus JN, Watson P, Lynch J. Familial breast cancer, family cancer syndromes, and predisposition to breast neoplasia. In: Bland KI, Copeland EM III, editors. The breast: comprehensive management of benign and malignant diseases. New York: WB Saunders Co, 1991:262-91.
4. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990;250:1684-9.
5. Narod SA, Feunteun J, Lynch HT, Watson P, Conway T, Lynch J, et al. Familial breast-ovarian cancer locus on chromosome 17q12-23. Lancet 1991;338:82-3.
6. Miki Y, Swensen J, Shattuck-Edens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266:66-71.
7. Easton DF, Bishop DT, Ford D, Crockford GP and the Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer. Results from 214 families. Am J Hum Genet 1993;52:678-701.
8. Stratton MR, Ford D, Neuhasen S, Seal S, Wooster R, Friedman LS, et al. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet 1994;7:103-7.
9. Wooster R, Heuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265:2088-91.
10. Moolgavkar SH, Knudson AG. Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst 1981;66:1037-52.
11. Weinberg RA. Tumor suppressor genes. Science 1991; 254:1138-46.
12. Albano WA, Recabaren JA, Lynch HT, Campbell AS, Mailliard JA, Organ CH, et al. Natural history of hereditary cancer of the breast and colon. Cancer 1982;50:360-3.
13. Porter DE, Dixon M, Smyth E, Steel CM. Breast cancer survival in BRCA1 carriers. Lancet 1993;341:184-5.
14. Porter DE, Cohen BB, Wallace MR, Smyth E, Dixon M, Steel CM, et al. Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br J Surg 1994;81:1512-5.
15. Feunteun J, Narod SA, Lynch HT, Watson P, Conway T, Lynch J, et al. A breast-ovarian cancer susceptibility gene maps to chromosome 17q21. Am J Hum Genet 1993;52:736-42.
16. Narod S. Counselling under genetic heterogeneity: a practical approach. Clin Genet 1991;39:125-31.
17. Narod SA, Ford D, Devilee P, Barkardottir RB, Lynch HT, Smith SA, et al. An Evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Am J Hum Genet 1995;56:254-64.
18. Hermanek P, Sobin LH, UICC TNM classification of malignant tumors. 4th edition. Berlin: Springer-Verlag, 1987:94-9.
19. Beahrs OH, Henson DE, Hutter RVP, Myers MH. American Joint Committee on Cancer. Manual for staging of breast cancer. 3rd edition. Philadelphia: JB Lippincott, 1988:145-50.
20. The World Health Organization. The World Health Organization histological typing of breast tumors-second edition. Am J Clin Pathol 1982;78:806-16.
21. Page DL, Anderson TJ, Sakamoto G. Infiltrating carcinoma: major histological types. In: Page DL, Anderson TJ, editors. Diagnostic histopathology of the breast. Edinburgh: Churchill Livingstone, 1987:193-235.
22. Mulcahy GM, Platt R. Pathologic aspects of familial carcinoma of the breast. In: Lynch HT, editor. Genetics and breast cancer. New York: Van Nostrand Reinhold, 1981:65-97.
23. Anderson DE. Genetic study of breast cancer: identification of a high risk group. Cancer 1974;34:1090-7.
24. Rosen PP, Lesser ML, Senie MA, Kinne DWQ. Epidemiology of breast carcinoma III: relationship of family history to tumor type. Cancer 1982;50:171-9.
25. Ridolfi RL, Rosen PP, Port A, Kinne D, Miké V. Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer 1977;40:1365-85.
26. Elston CW. Grading of invasive carcinoma of the breast. In: Page DL, Anderson TJ, editors. Diagnostic histopathology of the breast. Edinburgh: Churchill Livingstone, 1987:300-11.
27. Hedley D, Friedlander M, Taylor I, Rugg C, Musgrove E. Method for analysis of cellular DNA content using flow cytometry. J Histochem Cytochem 1983;31:1333-5.
28. Crissman JD, Zarbo RJ, Niebylski CD, Corbett T, Weaver D. Flow cytometric DNA analysis of colon adenocarcinomas. A comparative study of preparatory techniques. Mod Pathol 1988;1:198-204.
29. McDivitt RW, Stone KR, Craig RB, Palmer JO, Meyer JS, Bauer WC. A proposed classification of breast cancer based on kinetic information. Cancer 1986;57:269-76.
30. Rabinovitch PS. Practical considerations for DNA content and cell cycle analysis. In: Bauer KD, Duque RE, Shackney VT, editors. Clinical flow cytometry: principles and application. Baltimore: Williams & Wilkins, 1993:117-42.
31. Walker SH, Duncan DB. Estimation of the probability of an event as a function of several independent variables. Biometrika 1967;54:167-79.
32. Marcus JN, Watson P, Page DL, Lynch HT. The pathology and heredity of breast cancer in younger women. Monogr Natl Cancer Inst 1994;16:23-34.
33. Meyer JS, Prey MU, Babcock DS, McDivitt RW. Breast carcinoma cell kinetics, morphology, stage, and host characteristics: a thymidine labeling study. Lab Invest 1986;54:41-51.
34. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley and Sons, 1980:70-117.
35. Millis RR, Hanby AM, Girling AC. The breast. In: Sternberg SS, editor. Diagnostic surgical pathology. 2nd edition. New York: Raven Press, 1994:323-407.
36. Claus EB, Risch N, Thompson WD, Carter D. Relationship between breast histopathology and family history of breast cancer. Cancer 1993;71:147-53.
37. Stalsberg H, Thomas DB, Noonan EA. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives: histologic types of breast carcinoma in relation to international variation and breast cancer risk factors. Int J Cancer 1989;44:399-409.
38. Visscher DW, Zarbo RJ, Greenawald KA, Crissman JD. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast. Pathol Annu 1990;25(1):171-210.
39. Shackney SE, Smith CA, Miller BW, Burholt DR, Murtha K, Giles HR, et al. Model for the genetic evolution of solid tumors. Cancer Res 1989;49:3344-54.
40. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994;266:1821-8.
41. Dutrillaux B, Gerbault-Seureau M, Remvikos Y, Zafrani B, Prieur M. Breast cancer genetic evolution; I. Data from cytogenetics and DNA content. Breast Cancer Res Treat 1991;19:245-55.
42. Cornelisse CJ, Kuipers-Dijkhoorn N, van Vliet M, Hermans J, Devilee P. Fractional allelic imbalance in human breast cancer increases with tetraploidization and chromosome loss. Int J Cancer 1992;50:544-8.
43. Remvikos Y, Gerbault-Seureau M, Magdelénat H, Prieur M, Dutrillaux B. Proliferative activity of breast cancers increases in the course of genetic evolution as defined by cytogenetic analysis. Breast Cancer Res Treat 1992;23:43-9.
44. Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y. Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res 1991;51:5794-9.
45. Chen L-C, Neubauer A, Kurisu W, Waldman FM, Ljung B-M, Goodson III W, et al. Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer. Proc Natl Acad Sci U S A 1991;88:3847-51.
46. Takita K, Sato T, Miyagi M, Watatani M, Akiyama F, Sakamoto G, et al. Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes. Cancer Res 1992;52:3914-7.
47. Thor AD, Moore II DH, Edgerton SM, Kawaski ES, Reihsaus E, Lynch HT, et al. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 1992;84:845-55.
48. Glebov OK, McKenzie KE, White CA, Sukumar S. Frequent p53 gene mutations and novel alleles in familial breast cancer. Cancer Res 1994;54:3703-9.
49. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE, Increased cell division as a cause of human cancer. Cancer Res 1990;50:7415-21.
50. Cohen SM, Ellwein LB. Cell proliferation in carcinogenesis. Science 1990;249:1007-11.
51. Meyer JS. Cellular proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine: effects of menstrual phase, age, and oral contraceptive hormones. Hum Pathol 1977;8:67-81.
52. Russo J, Calaf G, Roi L, Russo IH. Influence of age and gland topography on cell kinetics of normal human breast tissue. J Natl Cancer Inst 1987;78:413-8.
53. Olsson H, Ranstam J, Baldetorp B, Ewers S-B, Fernö M, Killander D, et al. Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortions. Cancer 1991;67:1285-90.
54. Bewtra C, Watson P, Conway T, Read-Hippee C, Lynch HT. Hereditary ovarian cancer: a clinicopathological study, Int J Gynecol Pathol 1992;11:180-7.
55. Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 1995;9:444-50.
56. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994;266:120-2.
57. Nowak R. Breast cancer gene offers surprises. Science 1994;266:1796-9.
58. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Cancer Institute of Child Health and Human Development Oral-contraceptive use and the risk of breast cancer. N Engl J Med 1986;315:405-11.
59. Pike MC, Henderson BE, Krailo MD, Duke A, Roy S. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet 1983;ii:926-30.
60. Henderson BE, Ross RK, Pike MC. Hormonal chemoprevention of cancer in women. Science 1993;259:633-8.
61. Fisher ER, Gregorio RM, Redmond C, Fisher B. Tubulolobular invasive breast cancer: a variant of lobular invasive cancer. Hum Pathol 1977;8:679-83.
62. Eusebi V, Betts CM, Bussolati G. Tubular carcinoma: a variant of secretory breast carcinoma. Histopathology 1979;3:407-419.
63. Borg Å, Zhang Q-X, Johannsson O, Olsson H. High frequency of allelic imbalance at the BRCA1 region on chromosome 17q in both familial and sporadic ductal breast carcinomas. J Natl Cancer Inst 1994;86:792-4.
64. O'Reilly SM, Camplejohn RS, Barnes DM, Millis RR, Allen D, Rubens RD, et al. DNA index, S-phase fraction, histological grade and prognosis in breast cancer. Br J Cancer 1990;61:671-4.
65. Eskelinen M, Lipponen P, Papinaho S, Aaltomaa S, Kosma VM, Klemi P, et al. DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors and independent prognostic factors in female breast cancer. Int J Cancer 1992;51:555-61.
66. Remvikos Y, Beuzeboc P, Zajdela A, Voillemot N, Magdelénat H, Pouillart P. Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy. J Natl Cancer Inst 1989;81:1383-7.
67. Gamel JW, Meyer JS, Province MA. Proliferative rate by S-phase measurement may affect cure of breast carcinoma. Cancer 1995;76:1009-18.